Biocryst Pharmaceuticals Inc. – Investors and Politicians Who Own It

BCRX

Investors who own it

4 tracked investors, $267.6M in shares, each from their latest 13F.

InvestorValueShare of portfolio
Peter KolchinskyRA Capital Management, Q2 2026
$158.3M1.38%
Joseph EdelmanPerceptive Advisors, Q2 2026
$103.1M1.55%
Ray DalioBridgewater Associates, Q2 2026
$4.9M0.02%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$1.3M0.06%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

PoliticianEst. valueShare of portfolio
$15K0.03%
Josh GottheimerD-NJ · House
$8.6K0.03%
InvestorActionShares now
Peter KolchinskyNew15,827,186
Takis SparaggisSold out0
Joseph EdelmanNew3,162,529
Julian i Felix BakerNew2,822,727
Behzad AghazadehSold out0
Ray DalioReduced −43%235,572
Daniel SchneebergerNew45,000

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

PoliticianActionTraded
Bought$1K–$15KJul 10, 2026disclosed Sep 4, 2026
Bought$1K–$15KNov 13, 2025disclosed Dec 15, 2025
Josh GottheimerJointD-NJ · House
Bought$1K–$15KOct 16, 2023disclosed Nov 11, 2023
Josh GottheimerJointD-NJ · House
Sold$1K–$15KSep 15, 2023disclosed Oct 15, 2023
Josh GottheimerJointD-NJ · House
Bought$1K–$15KAug 11, 2022disclosed Sep 16, 2022